Valuation · US stocks

Iovance Biotherapeutics Inc (IOVA) valuation

As of 2026-11-18, Iovance Biotherapeutics Inc trades at $7.48, above its 1-year fair-value range, though within the widest range.

Price
$7.48
Day change
-0.66%
Market cap
$3.64B
Sector
Biotechnology
Valuation
High
Fair value
Sign up free to see the fair value and gap
As of
2026-11-18
Open the full valuation in Wave Radar

Options

Options price a move of ±8.28% to the 2026-11-20 expiry (implied volatility 74.61%). IOVA gamma exposure

Other Biotechnology stocks

StockPriceMarket capValuation
Amgen Inc. AMGN$443.89$251.94BHigh
Gilead Sciences, Inc. GILD$168.98$181.83BAbove band
Moderna, Inc. MRNA$196.79$93.61BAbove band
Natera, Inc. NTRA$289.50$44.78BFair
IQVIA Holdings Inc IQV$257.80$42.67BAbove band
United Therapeutics Corporation UTHR$577.34$24.09BAbove band
Neurocrine Biosciences, Inc. NBIX$162.86$16.76BFair
Summit Therapeutics Inc SMMT$10.50$13.99BFair
Elanco Animal Health, Inc. ELAN$26.69$13.41BAbove band
Halozyme Therapeutics, Inc. HALO$95.80$11.76BHigh
Twist Bioscience Corp. TWST$116.35$11.50BAbove band
Bio-Techne Corporation TECH$72.75$11.44BFair

How the valuation band works

Wave Radar estimates a fair-value range from each company's earnings, book value and its own historical P/E and P/B over 1, 3 and 5-year windows. The 1-year window gives the tight range; the widest bounds across all windows give the loose one. "Low" and "High" mean the price has left the tight range; "Below band" and "Above band" mean it has left even the widest one.

Read the method

Figures are generated automatically from Wave Radar's published market data and refresh after each market close.